Related Experiment Video

Updated: Jul 9, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

Emetine and the alternative splicing of Bcl-X: where to next?

Jacqueline C Shultz1, Charles E Chalfant

  • 1Department of Biochemistry, Virginia Commonwealth University School of Medicine, Richmond, VA 23298-0614, USA.

Chemistry & Biology
|December 22, 2007
PubMed

Insights

Targeting cancer cells by interfering with apoptotic factor alternative splicing is a novel strategy. Emetine, a protein synthesis inhibitor, regulates Bcl-x pre-mRNA splicing and involves a key signaling player.

Area of Science:

  • Molecular biology
  • Cancer research
  • Drug discovery

Background:

  • Alternative splicing of apoptotic factors presents a targeted approach against malignant cells.
  • Emetine, a protein synthesis inhibitor, influences cellular processes.
  • Understanding splicing regulation is crucial for developing targeted cancer therapies.

Discussion:

  • Zhou et al. investigate the impact of emetine on the alternative splicing of Bcl-x pre-mRNA.
  • The study identifies a key signaling component involved in this regulatory mechanism.
  • This research sheds light on how protein synthesis inhibition affects apoptosis-related gene expression.

Key Insights:

  • Emetine exposure leads to specific alterations in Bcl-x pre-mRNA splicing.
  • A significant signaling pathway player in emetine-induced splicing modulation has been identified.
  • The findings provide a deeper understanding of the molecular mechanisms underlying emetine's effects on cancer cells.

Outlook:

  • This work may pave the way for novel therapeutic strategies targeting cancer through splicing modulation.
  • Further research could explore other protein synthesis inhibitors and their effects on alternative splicing.
  • Identifying and targeting key players in splicing regulation could enhance the specificity of cancer treatments.

More Related Videos

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are: